Literature DB >> 21911828

Free protein S level as a risk factor for coronary heart disease and stroke in a prospective cohort study of healthy United Kingdom men.

Gie Ken-Dror1, Jackie A Cooper, Steve E Humphries, Fotios Drenos, Helen A Ireland.   

Abstract

Plasma protein S (PS) levels are reportedly low in patients with venous thrombosis but high in coronary heart disease (CHD) patients. The authors examined the association between free PS concentration and CHD or stroke risk and assessed risk in combination with C-reactive protein (CRP) levels. Free PS concentration was determined in 6 annual visits among 3,052 middle-aged (49-64 years) United Kingdom men from the Second Northwick Park Heart Study, with 297 CHD events from 1989 to 2005. The highest (vs. first) quintile was associated with a significantly increased CHD risk after adjustment for all other risk factors and correction for regression dilution bias (hazard ratio = 1.85, 95% confidence interval: 1.08, 3.16; P = 0.024). Models that included all well-known risk factors plus PS quintiles improved prediction of CHD (net reclassification improvement (NRI) = 7.0% (P = 0.007), category-less NRI (>0) = 22.1% (P < 0.001)), and the likelihood ratio statistic increased significantly (P = 0.018). The increase in CHD risk was particularly strong when subjects also had high CRP levels. There was no association between free PS level and stroke risk. This study confirms the independent association of elevated free PS levels with future risk of CHD, although elevated PS levels added only modestly to prediction metrics. The novel finding of increased CHD risk, particularly when CRP and PS levels are high, requires further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911828      PMCID: PMC3218631          DOI: 10.1093/aje/kwr203

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

Review 2.  The contribution of thrombosis to the clinical expression of coronary atherosclerosis.

Authors:  M J Davies
Journal:  Thromb Res       Date:  1996-04-01       Impact factor: 3.944

Review 3.  Inherited thrombophilia: Part 1.

Authors:  D A Lane; P M Mannucci; K A Bauer; R M Bertina; N P Bochkov; V Boulyjenkov; M Chandy; B Dahlbäck; E K Ginter; J P Miletich; F R Rosendaal; U Seligsohn
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

Review 6.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

Authors:  Robert J Kim; Richard C Becker
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

7.  TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.

Authors:  Chang-Hee Suh; Brendan Hilliard; Sophia Li; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

Review 8.  Acute myocardial infarction with normal coronary artery: a case report and review of literature.

Authors:  K J Manzar; F A Padder; A R Conrad; I Freeman; E A Jonas
Journal:  Am J Med Sci       Date:  1997-11       Impact factor: 2.378

Review 9.  C-reactive protein and coronary heart disease: predictive test or therapeutic target?

Authors:  Aroon D Hingorani; Tina Shah; Juan P Casas; Steve E Humphries; Philippa J Talmud
Journal:  Clin Chem       Date:  2008-12-29       Impact factor: 8.327

10.  Free protein S deficiency in acute ischemic stroke. A case-control study.

Authors:  S A Mayer; R L Sacco; A Hurlet-Jensen; T Shi; J P Mohr
Journal:  Stroke       Date:  1993-02       Impact factor: 7.914

View more
  3 in total

Review 1.  TAM receptors in cardiovascular disease.

Authors:  Lucy McShane; Ira Tabas; Greg Lemke; Mariola Kurowska-Stolarska; Pasquale Maffia
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

Review 2.  Vitamin K, Vascular Calcification, and Chronic Kidney Disease: Current Evidence and Unanswered Questions.

Authors:  M Kyla Shea; Sarah L Booth
Journal:  Curr Dev Nutr       Date:  2019-07-04

3.  Association of Nitric Oxide Synthase Polymorphism and Coagulopathy in Patients with Osteonecrosis of the Femoral Head.

Authors:  Cheng-Ta Wu; Rio L C Lin; Pei-Hsun Sung; Feng-Chih Kuo; Hon-Kan Yip; Mel S Lee
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.